Latest Crohn's disease Stories
Researchers from the Icahn School of Medicine at Mount Sinai recently published two manuscripts in the New England Journal of Medicine regarding a new antibody used to treat both ulcerative colitis
A statistical model accounting for dozens of different genes in combination—and the interactions between them—is an important step forward in understanding the genetic factors affecting the risk of Crohn's disease (CD).
Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis.
iPhone APP and mobile friendly website. Bala Cynwyd, PA (PRWEB) August 15, 2013 The Crohn’s & Colitis Foundation of America is getting more mobile
Saturday, September 21st, 2013 @ SugarHouse Casino Philadelphia, PA (PRWEB) August 01, 2013 The Philadelphia/Delaware Valley Chapter of the Crohn’s
Crohn’s Disease and Ulcerative Colitis More Common Amongst Ashkenazi Jews New York, New York (PRWEB) July 31, 2013 Individuals seeking to learn about
Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug in subjects with moderate to severe
- A transitional zone between two communities containing the characteristic species of each.